XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Market Comment – Yen on the front foot as BoJ hike eyed; stocks stage a recovery



  • Yen looks to extend gains as BoJ set to press ahead with policy normalization

  • Wall Street bounces back on hopes of upbeat tech earnings, Fed rate cut signal

  • Gold and oil in tepid rebound despite heightened tensions in Middle East

BoJ to kick off trio of central bank meetings

The Japanese yen edged higher on Monday as investors anticipate the Bank of Japan to take the next steps in its policy normalization plans when it announces its latest decision on Wednesday. Expectations are running high that the BoJ will not only reduce its bond purchases, but that it may also hike interest rates for a second time this year.

Investors anticipate the Bank of Japan to take the next steps in its policy normalization plans

It’s almost likely that there will be some form of an announcement on tapering this week, with some reports suggesting a halving of the monthly JGB purchases over the next few years. What is less certain is whether or not policymakers will also agree to raise rates or leave that decision for another meeting.

Investors have been upping their bets of a rate hike in recent weeks, pricing in around a two-thirds probability of a 10-basis-point increase, amid growing calls by Japanese government officials for the BoJ to do more to tackle the weak yen.

Yen on a roll

The yen has surged by about 4.5% against the US dollar this month. But much of the gains have been on the back of the unwinding of yen carry trades rather than on policy speculation.

Much of the gains have been on the back of the unwinding of yen carry trades rather than on policy speculation

Although the nearing of a BoJ hike and a Fed cut is undoubtedly adding fuel to the rally, the trigger seems to have been Trump’s recent comments on the strength of the dollar and the weak yen amongst others, which has set off a massive reversal of global carry trades. This in turn has sparked a short squeeze in the yen, further boosting the currency.

A rate hike accompanied by a hawkish tone could see the yen rallying further but it may also be the right time for a technical correction if the BoJ disappoints.

Rising odds of a BoE cut

The yen’s newfound strength has made for a mixed dollar, as commodity-linked currencies have sunk in the past couple of weeks, while the euro and pound have been somewhat more resilient. But sterling’s losses seem to be deepening as expectations grow that the Bank of England will cut rates on Thursday.

Sterling’s losses seem to be deepening as expectations grow that the Bank of England will cut rates on Thursday

The odds have risen from around 50% to almost 60% in the last few days, and although any decision to cut will likely be a close call, the optimism about looser monetary policy is contributing to the turnaround in risk sentiment. The Fed also meets this week, and many investors are betting that FOMC members will flag a rate cut in September even as they keep policy unchanged on Wednesday.

Stocks perk up, weak start for commodities

However, following last week’s upside surprises in Q2 GDP and core PCE readings, the Fed may not be ready to commit to a September cut just yet. This poses a downside risk for stocks, which are attempting a rebound after being on the slide since mid-July.

For Wall Street traders, however, the Fed will not be the only focus as there’s a flurry of tech earnings coming up, starting with Microsoft tomorrow.

In commodities, gold is struggling to reclaim the $2,400 level as the US dollar pulls higher, while oil prices are up only marginally despite a flare up in tensions in the Middle East. Israel is accusing Hezbollah of a rocket attack that killed 12 children on Saturday and has launched retaliatory strikes in Lebanon.

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques